Publications

  1. Stefansson, H. et al. CNVs conferring risk of autism or schizophrenia affect cognition in controls. Nature (2013).
  2. Ulfarsson, M.O. et al. 15q11.2 CNV affects cognitive, structural and functional correlates of dyslexia and dyscalculia. Translational Psychiatry 7(2017).
  3. Isles, A.R. et al. Parental Origin of Interstitial Duplications at 15q11.2-q13.3 in Schizophrenia and Neurodevelopmental Disorders. Plos Genetics 12(2016).
  4. Steinberg, S. et al. Truncating mutations in RBM12 are associated with psychosis. Nature Genetics 49, 1251-+ (2017).
  5. Euesden, J., Lewis, C.M. & O’Reilly, P.F. PRSice: Polygenic Risk Score software. Bioinformatics 31, 1466-1468 (2015).
  6. Power, R.A. et al. Polygenic risk scores for schizophrenia and bipolar disorder predict creativity. Nat Neurosci 18, 953-5 (2015).
  7. Reginsson, G.W. et al. Polygenic risk scores for schizophrenia and bipolar disorder associate with addiction. Addict Biol (2017).
  8. Iniesta, R. et al. Combining clinical variables to optimize prediction of antidepressant treatment outcomes. J Psychiatr Res 78, 94-102 (2016).
  9. Iniesta, R., Stahl, D. & McGuffin, P. Machine learning, statistical learning and the future of biological research in psychiatry. Psychol Med 46, 2455-65 (2016).
  10. Verbelen, M., Collier, D.A., Cohen, D., MacCabe, J.H. & Lewis, C.M. Establishing the characteristics of an effective pharmacogenetic test for clozapine-induced agranulocytosis. Pharmacogenomics J 15, 461-6 (2015).
  11. Verbelen, M. & Lewis, C.M. How close are we to a pharmacogenomic test for clozapine-induced agranulocytosis? Pharmacogenomics 16, 915-917 (2015).
  12. Lo, M.T. et al. Genome-wide analyses for personality traits identify six genomic loci and show correlations with psychiatric disorders. Nat Genet (2016).
  13. Vassos, E. et al. An Examination of Polygenic Score Risk Prediction in Individuals With First-Episode Psychosis. Biol Psychiatry (2016).
  14. Mullins, N. et al. Reproductive fitness and genetic risk of psychiatric disorders in the general population. Nature Communications 8(2017).
  15. Olafsson, S. et al. Fourteen sequence variants that associate with multiple sclerosis discovered by meta-analysis informed by genetic correlations. Npj Genomic Medicine 2(2017).
  16. Steinberg, S. et al. Common variant at 16p11.2 conferring risk of psychosis. Molecular Psychiatry 19, 108-114 (2014).
  17. Thygesen, J.H. et al. Linkage and whole genome sequencing identify a locus on 6q25-26 for formal thought disorder and implicate MEF2A regulation. Schizophrenia Research 169, 441-446 (2015).
  18. Luo, X.J. et al. Convergent lines of evidence support CAMKK2 as a schizophrenia susceptibility gene. Molecular Psychiatry 19, 774-783 (2014).
  19. Ripke, S. et al. Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nature Genetics 45, 1150-U282 (2013).
  20. Ripke, S. et al. Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet 45, 1150-9 (2013).
  21. Steinberg, S. et al. Common variant at 16p11.2 conferring risk of psychosis. Mol Psychiatry 19, 108-14 (2014).
  22. Luo, X.J. et al. Convergent lines of evidence support CAMKK2 as a schizophrenia susceptibility gene. Mol Psychiatry (2013).
  23. Navarrete, K. et al. TCF4 (e2-2; ITF2): a schizophrenia-associated gene with pleiotropic effects on human disease. Am J Med Genet B Neuropsychiatr Genet 162B, 1-16 (2013).